Antitumour necrosis factor-α agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: a retrospective cohort
Objective Elevated tumour necrosis factor (TNF)-α has been implicated in the progression of liver fibrosis and pathogenesis of non-alcoholic fatty liver disease (NAFLD). We aim to investigate the impact of anti-TNF-α agents on the development of cirrhosis and NAFLD.Design This retrospective cohort s...
Saved in:
| Main Authors: | Susan Hutfless, Ruben Hernaez, Kuo-Tung Tang, Jean-François Dufour, Po-Hung Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-12-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/7/1/e000349.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Learning the Lessons of Antitumour Necrosis Factor Therapy-Associated Psoriasis
by: Matt Shale, et al.
Published: (2009-01-01) -
Impact of antitumour necrosis factor therapy on surgery in inflammatory bowel disease: a population-based study
by: Richard C G Pollok, et al.
Published: (2024-07-01) -
Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01) -
Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis
by: Lubomir Skladany, et al.
Published: (2021-01-01) -
Evaluation of comorbidity in patients with alcoholic cirrhosis of the liver associated with non-alcoholic fatty liver disease
by: N. R. Matkovska, et al.
Published: (2020-04-01)